Tutorial
RH CHAIN
…
Wallet
Overview
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
01
Overview
02
Daily Brief
03
Live
04
Congress
05
Corporate Insiders
06
Government Money
07
Political Influence
08
Institutions
09
Washington Network
10
Follow the Power
11
Disclosure Clock
12
AI Investigator
13
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Overview
Daily Brief
Live
Congress
Corporate Insiders
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Match review
Launch readiness
Tutorial
Data sources
SEC FORM 4
2m ago
HOUSE PTR
1m ago
SEC 13F
1m ago
ROBINHOOD CHAIN
50s ago
Public company
OTLK
Outlook Therapeutics, Inc.
CIK 0001649989
EDGAR filings
Open in network
○
Watch OTLK
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
9
Connections
2
with evidence
OTLK · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
9
LM
Lundquist Kevin Michael
Chief Financial Officer
OTLK
Outlook Therapeutics, Inc.
Grant or award
A
—
500.0K sh
Sep 1, 2026
Sep 2, 2026
traded Sep 1, 2026
+1d
SEC FORM 4
Evidence
Evidence
Close
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Insider of
evidence
Lundquist Kevin Michael
Chief Financial Officer · Sep 2, 2026